CEPI Invests Over $60 Million to Accelerate Bundibugyo Ebola Vaccine Amid DRC Outbreak
The Coalition for Epidemic Preparedness Innovations (CEPI) announced emergency funding for three inv...
Novo Nordisk's Wegovy Oral Drug Receives Positive European Review, Plans to Launch in Spain
The European Medicines Agency has issued a positive review for the oral therapy Wegovy (semaglutide)...
China's self-developed first-in-class drugs entering clinical trials have increased 12-fold in a decade
The number of China's self-developed First-in-Class (FIC) drug candidates entering clinical trials g...
Newcastle University Develops ReJI Bioprinted 3D Tissue Models for Drug Screening
Dr. Priscila Melo, a Lecturer in Bioengineering at Newcastle University and co-founder of JetBio, is...
CorrectSequence's CS-206 Therapy Shows 15 Months Without Vaso-Occlusive Crisis
CorrectSequence Therapeutics Co., Ltd. has announced 15-month follow-up data for CS-206, a high-prec...
Australia's first $96 million RNA manufacturing facility opens in New South Wales
Australia's first dedicated RNA research and manufacturing facility, designed by HDR, has officially...
Japan's iPS Cell Regenerative Medicine Products Approved, Heart Failure and Parkinson's Treatment Entering New Clinical Application Stage
Japan's Ministry of Health, Labour and Welfare recently approved two regenerative medicine products ...
On May 29, China's Shenzhou returned space science samples, with a total weight of 41 kg including artificial embryos
The tenth batch of space science experiment samples from the China Space Station returned to Earth a...